Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyarticular Juvenile Rheumatoid Arthritis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)Study completedNCT01844518
What this trial is testing

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Active Polyarticular Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 219
Not applicableStudy completedNCT02593006
What this trial is testing

Start Time Optimization of Biologics in Polyarticular JIA

Who this might be right for
Polyarticular Juvenile Rheumatoid ArthritisArthritis, Juvenile Idiopathic
Hackensack Meridian Health 400
Large-scale testing (Phase 3)Study completedNCT02277444
What this trial is testing

Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 130
Not applicableStudy completedNCT05031104
What this trial is testing

Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic ArthritisRheumatic DiseasesChronic Knee Pain+3 more
Cairo University 60
Not applicableLooking for participantsNCT05754710
What this trial is testing

Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

Who this might be right for
Psoriatic Arthritis, JuvenilePolyarticular Juvenile Idiopathic Arthritis
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT01727986
What this trial is testing

An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT02776735
What this trial is testing

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Sanofi 102
Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Testing effectiveness (Phase 2)Study completedNCT00037648
What this trial is testing

Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Chronic Arthritis
Amgen 86
Large-scale testing (Phase 3)Study completedNCT02840175
What this trial is testing

Treatment Tapering in JIA With Inactive Disease

Who this might be right for
Juvenile Idiopathic Arthritis
Assistance Publique - Hôpitaux de Paris 62
Early research (Phase 1)Active Not RecruitingNCT03725007
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis (JIA)
AbbVie 124
Large-scale testing (Phase 3)Study completedNCT00036374
What this trial is testing

The Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis, Juvenile
Centocor, Inc. 123
Large-scale testing (Phase 3)Study completedNCT01015547
What this trial is testing

Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Helsinki University Central Hospital 60
Large-scale testing (Phase 3)Study completedNCT01835470
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 23
Large-scale testing (Phase 3)Study completedNCT00048542
What this trial is testing

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Arthritis, Juvenile Idiopathic
Abbott 171
Large-scale testing (Phase 3)Study completedNCT00095173
What this trial is testing

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Bristol-Myers Squibb 214
Not applicableStudy completedNCT05231057
What this trial is testing

Impact of Pilates Exercise in Children With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile ArthritisCardiorespiratory FitnessQuality of Life
Qassim University 40
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableStudy completedNCT03383263
What this trial is testing

Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)

Who this might be right for
Polyarticular Juvenile Arthritis
AbbVie 70
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Load More Results